All episodes of e-ESO Podcasts

Episodes

Approach to severe Immune-related adverse events: beyond corticosteroids and other challenges

Experts: Paula Fidalgo, Centro Hospitalar Universitário de Santo António, Porto, PT João Coelho, Centro Hospitalar Universitário de Santo António, Porto, PT

Published 04/30/24

e-ESO Podcasts

Published 04/30/24

Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

Expert: Panagiotis J. Vlachostergios, Weill Cornell Medicine, New York, NY, USA

Published 04/18/24

The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

Expert: Franco Cavalli, Foundation for the Institute for Oncology Research (IOR), Bellinzona, Switzerland

Published 04/04/24

Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil

Published 03/20/24

An inter-specialty cancer training programme curriculum for Europe

Kim Benstead, Co-Chair INTERACT-EUROPE Project, Cheltenham, UK

Published 03/07/24

Communicating the oncological diagnosis: a psycho-oncological perspective

Expert: Adrian Pogacian, INCKA Psycho-Oncology Center, Târgu Mures, Romania

Published 02/22/24

ESMO 2023 Highlights on lung cancer

Expert: Mohamed Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt

Published 02/08/24

Cyclophosphamide induced severe hyponatremia with encephalopathy and seizure in a patient with locally advanced breast cancer

Expert: Sofiko Sharashenidze, Mardaleishvili Medical Centre, Tbilisi, Georgia

Published 01/25/24

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

Expert: Salah Mabrouk Khallaf, South Egypt Cancer Institute, Assiut, Egypt

Published 01/24/24

Radiotherapy as a local hemostatic agent in cancer patients

Expert: Mohammad Nasser Ahmed, National Oncology Center, Sanaa, Yemen Republic

Published 11/30/23

News on Breast Cancer from ESMO 2023

Expert: Elvina Almuradova, Medicana International Hospital, Izmir, Turkey

Published 11/23/23

Challenge of diagnosis of metachronous ovarian metastases in a young patients with primary colorectal cancer

Expert: Zaiana Sangadzhieva, Institute for Personalized Oncology of Sechenov University, Moscow, RU

Published 11/16/23

How to make the treatment choice in localized adenocarcinoma of the lower oesophagus and GEJ after the NeoAegis trial results

Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil

Published 11/09/23

ESO Experiences

Expert: Rita Canario, University of Porto, Porto, Portugal

Published 11/02/23

THE ERA OF CDK4/6 inhibitors in early breast cancer concerning staging the axilla. A surgeon’s perspective

Expert: Lazaros Papadopoulos, IASO Gynecological Clinic, Athens, Greece

Published 10/26/23

SELNET clinical practice guidelines for bone sarcoma

Expert: Bruna David, National Cancer Institute, Rio de Janeiro, Brazil

Published 10/19/23

Switching treatment paradigms and the difficulties with this

Experts: Sara Ramella, Campus Bio-Medico University, Rome, Italy Pierfilippo Crucitti, Campus Bio-Medico University, Rome, Italy

Published 10/12/23

Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors

Expert: Amalya Sargsyan, Hematology Center After Prof Yeolyan, Yerevan, Armenia

Published 10/01/23

Surgical management of breast cancer in BRCA-mutation carriers

Expert: Nicola Rocco, University Hospital Federico II, Naples, Italy

Published 09/28/23

ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma - Radiotherapy and Oncology

Expert: Sara Simões, Braga Public Hospital, Braga, Portugal

Published 09/22/23

The usage of AI in oncology

Expert: Livio Fenga, University of ExeterExeter, United Kingdom

Published 09/14/23

Clinical use of radiomics

Expert: Stefania Volpe, European Institute of Oncology Milan and University of Milan, Milan, Italy

Published 09/06/23

Why do we need mentoring in oncology

Expert: Malgorzata Osmola, University Clinical Centre - Medical University of Warsaw, Warsaw, Poland

Published 07/27/23

Lessons from the ANCHOR-CRC Trial: The challenge of BRAF in metastatic Colorectal Cancer

Expert: Marcelo Porfirio Sunagua Aruquipa, AC Camargo Cancer Center, San Paolo, Brazil

Published 07/14/23